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Abstract
Background: Specific genotypes of several virulence factors of Helicobacter pylori (eg, cagA-positive, vacA s1, oipA
“on” and babA-positive) have been reported to be predictors of severe clinical outcomes. Importantly, the presence
of these genotypes correlates with each other. We hypothesized that novel virulence genes correlate with the
presence of cagA. Therefore, we aimed to find novel candidate virulence genes that correlate with cagA and
examined the association of these genes with clinical outcomes in Colombian and Japanese populations.
Methods: cagA-associated genes were selected based on previous H. pylori genome microarray data. A total of 343
strains (174 from Colombia and 169 from Japan) were examined for the status of cagA, vacA, and candidate genes
by polymerase chain reaction and dot blot.
Results: Microarray data showed that 9 genes were significantly correlated with the presence of cagA. Among the
9 genes, the functions of 4 were known, and we selected these 4 genes as candidate genes (hp0967, jhp0045,
jhp0046, and jhp0951). The prevalences of cagA, vacA s1/m1 genotype, and hp0967 were significantly higher in
Japan than Colombia, whereas those of jhp0045 and jhp0046 were more prevalent in Colombia than Japan. The
prevalences of jhp0045 and jhp0046 in cagA-positive cases of gastric cancer were significantly higher than those
from gastritis in Colombia (P = 0.015 and 0.047, respectively). In contrast, the prevalence of 4 candidate genes was
independent of clinical outcomes in Japan.
Conclusions: jhp0045 and jhp0046 might be novel markers for predicting gastric cancer in cagA-positive cases in
Colombia, but not in Japan.
Background
Helicobacter pylori (H. pylori) infection is now accepted
as the major cause of chronic gastritis. In addition, sev-
eral epidemiological studies have shown that H. pylori
infection is linked to severe gastritis-associated diseases,
including peptic ulcer and gastric cancer (GC) [1]. In
1994, the International Agency for Research on Cancer
categorized H. pylori infection as a group I carcinogen
[2]. Although GC is one of the most common cancers,
only a minority of individuals with H. pylori infection
ever develop it. The prevalence of GC is approximately
3% in H. pylori-positive patients [3].
In addition to environmental factors (eg, diet) and
host factors, virulence factors of H. pylori, such as cagA,
vacA, oipA, babA, hopQ, and homA/B, have been
demonstrated to be predictors of gastric atrophy, intest-
inal metaplasia, and severe clinical outcomes [4-10]. The
most studied virulence factor of H. pylori is cagA, which
is located at the end of an approximately 40-kb cluster
of genes called cag pathogenicity island (PAI). cag PAI
encodes a type-IV secretion system and transfers CagA
protein into host cells [11]. CagA protein is believed to
have oncogenic potential [12,13], and cagA-positive
strains are reported to be associated with severe clinical
outcomes [14].
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However, these factors are not enough to distinguish
markers for severe outcomes (eg, GC) in Japan because
most H. pylori strains isolated in Japan possess these
virulence factors. Likewise, our previous report showed
that these genes were not virulence markers for GC in
Colombia [10]. Importantly, the presence of these geno-
types correlate with each other; the cagA-positive strain
usually possesses the vacA s1/m1 genotype, and it is
further closely linked to the presence of babA and oipA
“on” status [14]. Therefore, we hypothesized that novel
virulence genes correlate with the presence of cagA.
Although cagA is not a distinguishing marker for severe
outcomes in Japan and Colombia, the importance of
cagA has been shown in both in vitro and in vivo
experiments [14]. For example, our study showed that
histological scores were significantly higher in cagA-
positive subjects than cagA-negative ones, even in Japan
[15]. Therefore, subjects infected with cagA-positive H.
pylori can be considered as a higher risk population
than those with cagA-negative strains, even in Japan and
Colombia. However, only a minority of individuals with
cagA-positive H. pylori infection develop severe out-
comes in both countries. This suggests that other viru-
lence factors in cagA-positive strains are necessary to
develop severe outcomes.
Previous whole H. pylori genome microarray data
revealed that several genes were associated with the pre-
sence of cagA and/or clinical outcomes. For example,
Romo-González et al. examined 42 H. pylori strains and
found that several genes were associated with gastroduo-
denal diseases [16]. In addition, Salama et al. used the
microarray of 15 H. pylori strains and identified several
genes that correlated with the presence of cag PAI [17],
although they did not examine the association between
these genes and clinical outcomes. However, these micro-
array data are not sufficient as conclusive evidence of the
association due to the small sample size. Previously, we
also performed whole H. pylori genome microarray and
examined 1,531 genes, including cagA, in 56 H. pylori
strains isolated from several countries [18].
In this study, we aimed to find novel candidate viru-
lence genes that correlate with the presence of cagA,
and we examined the association of these genes with




Initially, candidate genes were selected from previous
studies by Salama et al. [17] and Romo-González et al.
[16]. Microarray data from 56 strains in our previous
report was then used for the examination of the associa-
tion of candidate virulence genes with the presence of
cagA [18].
Patients
H. pylori strains were obtained from the gastric mucosa
of H. pylori-infected patients who underwent endoscopy
at Oita University Faculty of Medicine, Oita, Japan, and
Universidad Nacional de Colombia, Bogota, Colombia.
Presentations included gastritis, duodenal ulcer (DU),
gastric ulcer (GU), and GC. DU, GU, and GC were
identified by endoscopy, and GC was further confirmed
by histopathology. Gastritis was defined as H. pylori gas-
tritis in the absence of peptic ulcers or gastric malig-
nancy. Patients with a history of partial gastric resection
were excluded. Patients who received H. pylori eradica-
tion therapy or treatment with antibiotics, bismuth-con-
taining compounds, H2-receptor blockers, or proton
pump inhibitors within 4 weeks prior to the study were
also excluded. Informed consent was obtained from all
participants, and the protocol was approved by the
ethics committees of Oita University and Universidad
Nacional de Colombia.
H. pylori genotyping
Antral biopsy specimens were obtained for the isolation
of H. pylori using standard culture methods, as pre-
viously described [19]. Chromosomal DNA was
extracted from confluent plate cultures expanded from a
single colony using a commercially available kit (QIA-
GEN Inc., Valencia, CA, USA). Two H. pylori strains
with full-sequenced genomes, 26695 (ATCC 700392)
and J99 (ATCC 700824) deposited in the GenBank,
were used as control strains. The cagA status was deter-
mined by polymerase chain reaction (PCR) using primer
pair 5’-ACC CTA GTC GGT AAT GGG-3’ and 5’-GCT
TTA GCT TCT GAY ACY GC-3’ (Y = C+T), as
described previously [20]. The vacA genotyping (s1, s2,
m1, and m2) was performed by PCR, as described pre-
viously [21,22]. Primers for the signal region yielded a
fragment of 259 bp for s1 variants and one of 286 bp
for s2 variants. Primers for the middle region yielded a
fragment of 570 bp for m1 variants and one of 645 bp
for m2 variants.
Two primer sets for each candidate gene were
designed with software Primer 3 (version. 0.4.0) based
on the published sequences of H. pylori (Table 1).
Amplification of H. pylori genomic DNA sequences was
carried out in a total volume of 25 μL containing 2.5 μL
of PCR buffer, 0.2 mM of each deoxynucleotide, 0.625
U of Blend Taq DNA polymerase (Blend Taq, Toyobo
Co., Ltd., Osaka, Japan), 0.2 μM of each primer, and
more than 10 ng of H. pylori DNA. Each reaction mix-
ture was amplified as follows: initial denaturation at 94°
C for 5 min, which was followed by 30 cycles of dena-
turation at 94°C for 30 s, annealing at the indicated tem-
perature in Table 1 for 30 s, extension at 72°C for 1
min, and then final extension at 72°C for 5 min. The
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amplified fragment was detected by 2.0% agarose gel
electrophoresis using an ultraviolet transilluminator.
Dot blot
For each sample, 500 ng of total DNA was added to 100
μL of TE buffer and mixed with 100 μL of a denaturing
buffer (0.5 M NaOH; 1.5 M NaCl). The denatured DNA
was transferred to a Hybond-N+ membrane (GE Health-
Care, Piscataway, NJ, USA) by means of a Bio-Dot
Microfiltration Apparatus (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). DNA of J99 and human DNA were
also transferred to the membrane and used as positive
and negative controls, respectively. The membranes
were hybridized at 42°C overnight in plastic bags con-
taining ECL Gold hybridization buffer supplemented
with 5% (wt/vol) blocking agent and 0.5 M NaCl. The
membranes were washed 3 times in primary washing
buffer (0.5× SSC [1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate] [pH 7.0], 0.4% sodium dodecyl sulfate)
at room temperature for 15 min and 3 times in second-
ary washing buffer (2× SSC) at room temperature for 15
min. Finally, the membranes were exposed to Hyperfilm
ECL film (GE HealthCare). Gene status was considered
positive when at least one of the PCR reactions was
positive. When gene status was considered negative by
PCR, we further confirmed the results using dot-blot
analyses. If PCR results yielded negative results but the
dot blot showed a positive blot, we considered the sam-
ples positive.
DNA sequencing
DNA sequencing for the full length of jhp0045 (1,032 bp)
was performed with several primer pairs located at
jhp0044 and jhp0046. Likewise, DNA sequencing for the
full length of jhp0046 (783 bp) was performed with sev-
eral primer pairs located at jhp0045 and jhp0047. PCR
products were purified with Centri-sep Columns
(Applied Biosystems by Life Technologies, Tokyo, Japan),
and the amplified fragments were sequenced with Hi-Di
Formamide (Applied Biosystems by Life Technologies)
using an ABI Prism 310 Genetic Analyzer (Applied
Biosystems by Life Technologies, Carlsbad, CA, USA) in
accordance with the manufacturer’s instructions.
Statistical analysis
Variables such as gender, mean age, and the presence of
each candidate gene and cagA were evaluated. The uni-
variate association between each genotype and the clinical
outcomes were quantified by the chi-square test. A multi-
variate logistic regression model was used to calculate the
odds ratios (OR) of the clinical outcomes by including age,
sex, and H. pylori genotypes. All determinants with P
values of < 0.10 were entered together in the full model of
logistic regression, and the model was reduced by exclud-
ing variables with P values of > 0.10. ORs and 95% confi-
dence intervals (CIs) were used to estimate the risk.
Spearman rank coefficients (r) were also determined to
evaluate the association between the different genotypes of
the strains. A P value of less than 0.05 was accepted as sta-
tistically significant. The SPSS statistical software package
version 18.0 (IBM Corporation, Armonk, NY, USA) was
used for all statistical analyses.
Results
Selection of candidate genes
Twelve genes that were strongly associated with cagA
status in the report by Salama et al. [17] were selected.
In addition, 26 genes that were associated with severe
gastric diseases in the report by Romo-González et al.
[16] were selected. Because hp1426 was reported in
both reports, a total of 37 genes were selected as candi-
date genes, as shown in additional file 1.
Among the 37 genes, the status of 9 genes (hp0186,
hp0713, hp0967, hp1409, hp1410, jhp0045, jhp0046,
jhp0950, and jhp0951) were significantly correlated with
the cagA status in our microarray data [18] (P = 0.026,
0.026, 0.014, 0.048, 0.030, 0.033, 0.033, 0.017, and 0.005
for each above gene, respectively). Among the 9 genes, 4
genes (hp0967, jhp0045, jhp0046, and jhp0951) were
selected in our analyses because the functions of these
genes are known. The presence of 3 genes (hp0967,
jhp0045, and jhp0046) was inversely correlated with the
Table 1 Primer sequences
Primer Name Primer Sequence (5’-3’) Forward Primer Sequence (5’-3’) Reverse AT (°C) Product size
hp0967-1 CATGGCTTTAAATGGCAACA CCGGCATTAAATCGTTGTTT 58 169
hp0967-2 TAGCGTGTATTTTGGCGATG GATAGCCGGCATTAAATCGT 59 151
jhp0045-1 TGGCAAAAGAGTCCAAGACA CGTTGCAATAAAAACGCAGA 59 180
jhp0045-2 AAAACAACGCCTGGTATTGC GATTGCACTTTATGCGTGTGA 60 158
jhp0046-1 AAGCAAGCGATAATGTCATGG AATTGAGCGTTTTGGTGTCC 59 154
jhp0046-2 AGCAAGCGATAATGTCATGG AATTGAGCGTTTTGGTGTCC 58 153
jhp0951-1 CAAAGCGTGAATGATTTGGA AGATTGCGCAAGGATTTGAG 56 194
jhp0951-2 ATGCGTGGCTAAGCGATACT GACCCAACGCTCTTGAAGTT 57 243
AT; annealing temperature
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presence of cagA, but that of jhp0951 was positively cor-
related with the presence of cagA. We examined the
presence of these candidate genes in 28 full sequenced
strains deposited in Genbank. The hp0967, jhp0045,
jhp0046, and jhp0951 were found in 18, 7, 7, and 13
strains, respectively.
Prevalence of candidate genes in Japan and Colombia
The distribution of the status of cagA, vacA, hp0967,
jhp0045, jhp0046, and jhp0951 in the two countries is
shown in Table 2. Three samples from Colombia showed
the positive for both vacA m1 and m2 genotypes, which
suggest the mixed infection, were excluded in the final ana-
lysis. Finally, a total of 343 patients were included in this
study: 174 from Colombia (68 with gastritis, 43 with DU,
and 63 with GC) and 169 from Japan (49 with gastritis, 50
with DU, 50 with GU, and 20 with GC). The results from
PCR and dot blot matched well: there were no cases with
negative results by PCR and only positive results by dot
blot. There were significant differences in the status of
cagA, hp0967, jhp0045, and jhp0046 between strains iso-
lated from Japanese and Colombian populations. The pre-
valence of cagA was 100% in Japan, whereas it was 65.5% in
Colombia (P < 0.0001). Higher prevalences of vacA s1 and
m1 genotypes were found in Japan than Colombia (100 vs.
76.8%, P < 0.001; 100 vs. 62.7%, < 0.001, respectively). The
prevalence of hp0967 was significantly higher in Japan than
Colombia (62.1 vs. 48.0%, P = 0.013). However, the preva-
lences of jhp0045 and jhp0046 were more prevalent in
Colombia than Japan (23.7 vs. 8.9%, P < 0.0001; 28.2 vs.
8.9%, P < 0.0001, respectively). There was no difference in
the prevalence of jhp0951 between the 2 countries.
The association between candidate genes and clinical
outcomes in Colombia
The prevalence of each gene was examined according to
clinical outcomes. The prevalence of the vacA m1 geno-
type was significantly higher in strains from patients
with GC than those with gastritis (75.0 vs. 55.1%, P =
0.014) (Table 2). Although it is accepted that cagA is an
important virulence factor, the prevalence of cagA was
not different between the strains from patients with DU,
GC, and gastritis in Colombia (61.4, 70.3, and 63.8%, P
> 0.05), which was in agreement with our previous
study [23]. Therefore, we hypothesized that the pre-
sence/absence of novel factors that accompany the pre-
sence of cagA leads to severe clinical outcomes in the
Colombian population. Based on this hypothesis, the
prevalences of these 4 candidate genes were examined
in the cagA-positive cases. In cagA-positive cases, vacA
status was not associated with clinical outcomes. Inter-
estingly, the prevalence of jhp0045 in cagA-positive
cases from GC was significantly higher than that of gas-
tritis (30.4 vs. 11.4%, P = 0.023) (Table 3). The preva-
lence of jhp0046 in cagA-positive cases from GC also
tended to be higher than that of gastritis (34.8 vs. 18.2%,
P = 0.06), although this did not reach statistical signifi-
cance. However, there were no associations of these
candidates between gastritis and DU. Table 4 shows the
association determined by a multivariate analysis
between clinical outcomes and the presence of jhp0045
or jhp0046 in cagA-positive cases in the Colombian
population. After adjustment for age and gender,
jhp0045 was an independent factor for discriminating
GC from gastritis in cagA-positive cases (adjusted OR =
3.24; 95% CI = 1.00-10.42; Table 4). Likewise, jhp0046
was an independent factor for discriminating GC from
gastritis in cagA-positive cases (adjusted OR = 3.16; 95%
CI = 1.05-9.47). On the other hand, the prevalences of
hp0967 and jhp0951 in cagA-positive cases were not
associated with clinical outcomes.
The association between candidate genes and clinical
outcomes in Japan
All samples from Japan showed cagA-positive and vacA
s1m1. The prevalences of the 4 candidate genes in
Table 2 Relationship between each gene and clinical outcomes in Colombia
Total gastritis DU GC
n 174 68 43 P 63 P
mean age 53.4 ± 16.4 52.0 ± 16.5 48.4 ± 15.9 0.50 58.1 ± 15.5 0.01
male 90 (50.8%) 28 (40.6%) 22 (50.0%) 0.30 40 (62.5%) 0.01
cagA 116 (65.5%) 44 (63.8%) 27 (61.4%) 0.83 45 (70.3%) 0.41
vacA s1 136 (76.8%) 50 (72.5%) 33 (75.0%) 0.70 54 (84.4%) 0.08
vacA m1 111 (62.7%) 38 (55.1%) 26 (59.1%) 0.63 48 (75.0%) 0.01
hp0967 85 (48.0%) 33 (47.8%) 20 (45.5%) 0.83 32 (50.0%) 0.79
jhp0045 42 (23.7%) 14 (20.3%) 13 (29.5%) 0.24 15 (23.4%) 0.65
jhp0046 50 (28.2%) 18 (26.1%) 15 (34.1%) 0.34 17 (26.6%) 0.94
jhp0951 102 (57.6%) 40 (58.0%) 26 (59.1%) 0.86 36 (56.3%) 0.84
DU, duodenal ulcer; GC, gastric cancer
*P value was compared with gastritis
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cagA-positive cases were independent of clinical out-
comes (Table 5).
Sequence analysis of jhp0045 and jhp0046 in Colombia
and Japan
In order to clarify whether the sequence variants in
jhp0045 and jhp0046 contributed to the different out-
comes in Colombia and Japan, sequences of these 2
genes were compared using 8 randomly selected strains.
For jhp0045, one-point mutation in the Japanese strains
was found at 643-bp position of J99 (A643G). Therefore,
the amino acid was changed from Ile to Val. The
sequence of jhp0045 from the Colombian strains
matched with J99. On the other hand, there was no dif-
ference in the sequence of jhp0046 between the strains
from the 2 countries.
Nucleotide sequence accession numbers
The nucleotide sequences of jhp0045 and jhp0046 for 8
strains (Japanese strains: 01-401, 04-156, 05-262, and
07-238; Colombian strains: Colombia 64, Colombia 114,
Colombia 174, and Colombia 229) have been deposited
in the GenBank database under accession no. AB647162
to AB647169 for jhp0045 and AB647170 to AB647176
for jhp0046, respectively.
Discussion
Our study revealed that jhp0045 and jhp0046 were inde-
pendent discriminating factors for GC from gastritis in
cagA-positive cases in Colombia. This suggests that
jhp0045 and jhp0046 play a role in high-risk subjects,
such as cagA-positive H. pylori-infected cases.
Several genes of H. pylori were reported as virulence
factors, and these include cagA, vacA, oipA, babA,
hopQ, and homA/B [4-10]. Importantly, most virulence
factors correlated with each other; cagA-positive strains
also possess the vacA s1/m1 genotype, and this is closely
linked to the presence of the babA and oipA “on” status
[14]. Therefore, we hypothesized that undefined novel
virulence genes could exist in genes correlated with
cagA status. Although previous microarray data showed
that several genes correlated with cagA status, the sam-
ple number in these microarray reports was not enough
to be conclusive (eg, [15] strains in the report by Salama
et al. [17]). Among the 37 genes we selected, 9 genes
were significantly correlated with the presence of cagA.
In the present study, we focused on 4 genes whose func-
tions have been revealed. hp0967 is considered a viru-
lence-associated protein D, and jhp0951, which encodes
an integrase of the XerCD family, has been reported to
be related to modifications in the response to low pH
and iron limitations [16,24]. The putative functions of
jhp0045 and jhp0046 have been described as type-II
DNA methyltransferase and type-II restriction enzymes,
respectively [17,25].
Among these 4 genes, jhp0045 and jhp0046 were sig-
nificantly associated with severe clinical outcomes in
cagA-positive cases in Colombia. Although hp0967 has
been reported to be negatively associated with DU [16],
there was no association in this study. The jhp0951 has
been positively associated with DU [16]; however, an
association was not found in this study. These findings
suggest that these microarray data are not conclusive. A
larger group of subjects is necessary to clarify the
association.
Table 3 Relationship between each gene and clinical outcomes in cagA-positive cases in Colombia
Gastritis DU GC
n 44 27 P 45 P
mean age 51.0 ± 15.3 47.2 ± 14.3 0.51 57.6 ± 14.3 0.02
male 19 (43.2%) 13 (46.4%) 0.68 31 (67.4%) 0.02
vacA s1 42 (95.5%) 24 (85.7%) 0.27 42 (91.3%) 0.51
vacA m1 33 (75.0%) 19 (67.9%) 0.66 36 (78.3%) 0.37
hp0967 24 (54.5%) 12 (42.9%) 0.40 27 (58.7%) 0.60
jhp0045 5 (11.4%) 7 (25.0%) 0.10 14 (30.4%) 0.02
jhp0046 8 (18.2%) 7 (25.0%) 0.43 16 (34.8%) 0.06
jhp0951 25 (56.8%) 19 (67.9%) 0.25 27 (58.7%) 0.76
DU, duodenal ulcer; GC, gastric cancer
*P value was compared with gastritis
Table 4 Multivariate analyses of the risk for GC by age,
gender, and jhp0045 or jhp0046 status in cagA-positive
cases in Colombia
Adjusted OR 95% CI P
Age (per 1 year) 1.02 0.99-1.05 0.10
Gender (male) 3.19 1.29-7.89 0.01
jhp0045 3.24 1.00-10.42 0.04
Age (per 1 year) 1.02 0.99-1.05 0.11
Gender (male) 3.15 1.27-7.80 0.01
jhp0046 3.16 1.05-9.47 0.03
CI, confidence interval; GC, gastric cancer; OR, odds ratio
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The mechanisms of the development of GC in those
patients infected with jhp0045 or jhp0046 are unclear,
although the putative functions of jhp0045 and jhp0046
have been described as a type-II DNA methyltransferase
and a type-II restriction enzyme, respectively [17,25]. In
this study, most strains possessing jhp0045 had jhp0046.
This suggests that these 2 genes may work together.
This combination of a restriction enzyme and a methyl-
transferase is known as a restriction-modification (R-M)
system [26]. It has been reported that H. pylori possess
an extraordinary number of genes with homology to R-
M genes in other bacterial species [25,27,28]. However,
not all R-M systems have that function. Kong et al.
reported that, among the 16 completely tested Type II
R-M systems in J99, only 4 were fully functional in that
they contained both active endonucleases and methy-
lases [29]. The jhp0045 and jhp0046 were included in
these functional ones. Because several R-M systems are
correlated with pathogenicity [26], strains possessing
jhp0045 and jhp0046 may be considered as truly virulent
strains. Interestingly, recent reports showed that H.
pylori strains possessing cagA from Colombia can be
divide into 2 groups by 7 housekeeping genes [30]. This
grouping was related with severe histological scores and
the prevalence of GC. The jhp0045 and jhp0046 may be
a discriminating factor for this grouping. Further study
is necessary in order to examine the relationship
between jhp0045 and jhp0046 and the grouping by 7
housekeeping genes.
Only 1 change of an amino acid resulted from a point
mutation of jhp0045 in Japanese strains compared with
Colombian strains and J99. It is not clear whether this
difference contributed to the different results between
the 2 countries. Variants of virulence factors in different
areas may result in different clinical outcomes. For
example, cagA can be divided into 2 types (East-Asian-
type cagA and Western-type cagA) according to differ-
ences in the 3’ region [6,20,21]. Some reports have
shown that individuals infected with East-Asian-type
cagA strains have an increased risk of peptic ulcer or
GC compared to those infected with Western-type cagA
strains [31,32]. Further studies to clarify the mechanisms
or functions according to the different amino acid
sequences are necessary to explain this.
Our study had several limitations. First, not only the
H. pylori virulence factors, but also environmental fac-
tors (eg, diet) and host factors have been demonstrated
to be predictors of severe clinical outcomes [33]. Espe-
cially, inflammatory cytokine gene polymorphisms (IL-1
gene cluster, TNF-a, IL-10, and IL-8) have been
reported to be correlated with gastric cancer [34-39].
Further study will be necessary in order to elucidate the
role of our candidate genes of H. pylori. Second, we did
not examine known virulence factors other than cagA
and vacA of H. pylori. It is possible that our candidate
genes might correlate with other known virulence fac-
tors, even in cagA-positive cases. It is better to examine
host factors and other known virulence factors in order
to clarify the role of our candidate genes in future stu-
dies. Finally, we examined the status of the genes by
only positivity or negativity. The levels of gene expres-
sion can be affected by clinical outcomes. In addition,
gene expression is not always correlated with protein
expression patterns. For example, the expression of the
blood group antigen-binding adhesin (BabA) protein is
not always correlated with babA gene expression [40].
Further analysis using real-time PCR or immunoblotting
techniques is necessary to clarify the significance of our
candidate genes.
Conclusions
The jhp0045 and jhp0046 were associated with GC in
cagA-positive cases in Colombia but not in Japan. In
Colombia, the status of jhp0045 and jhp0046 may pre-
dict the future development of GC for patients with gas-
tritis. A prospective study is necessary to confirm this.
Moreover, the study of the distribution of these genes in
other populations would be interesting in order to
Table 5 Prevalence of each gene and relationship between each gene and clinical outcomes in Japan
Total gastritis DU GU GC
n 169 49 50 P 50 P 20 P
mean age 60.0 ± 12.8 59.3 ± 12.8 56.0 ± 13.6 0.19 62.9 ± 12.1 0.25 64.3 ± 9.4 0.13
male 91 (53.8%) 24 (49.0%) 29 (58.0%) 0.36 27 (54.0%) 0.61 11 (55.0%) 0.65
cagA 169 (100.0%) 49 (100.0%) 50 (100.0%) - 50 (100.0%) - 20 (100.0%) -
vacA s1 169 (100.0%) 49 (100.0%) 50 (100.0%) - 50 (100.0%) - 20 (100.0%) -
vacA m1 169 (100.0%) 49 (100.0%) 50 (100.0%) - 50 (100.0%) - 20 (100.0%) -
hp0967 105 (62.1%) 30 (61.2%) 31 (62.0%) 0.93 34 (68.0%) 0.48 10 (50.0%) 0.39
jhp0045 15 (8.9%) 2 (4.1%) 6 (12.0%) 0.14 5 (10.0%) 0.22 2 (10.0%) 0.32
jhp0046 15 (8.9%) 2 (4.1%) 6 (12.0%) 0.14 5 (10.0%) 0.22 2 (10.0%) 0.32
jhp0951 108 (63.9%) 31 (63.3%) 30 (60.0%) 0.73 35 (70.0%) 0.47 12 (60.0%) 0.80
DU, duodenal ulcer; GU, gastric ulcer; GC, gastric cancer
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further elucidate the associations found in the present
study and the possible virulence role of these factors in
H. pylori infection.
Additional material
Additional file 1: Selected 37 genes. A total of 37 genes were selected
as candidate genes from two reports (Salama et al. [17] and Romo-
González et al. [16]).
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